Role of MTHFR polymorphisms and folate levels in different phenotypes of sporadic colorectal cancers
Background and aims
By altering both DNA methylation and nucleotide synthesis, folate metabolism is thought to contribute to colorectal carcinogenesis. We examined the role of folate metabolism in three different phenotypes of sporadic colorectal cancers (CRCs), phenotypes that were classified by the status of microsatellite instability (MSI) and chromosomal instability (CIN): MSI-H, microsatellite stability (MSS)/aneuploidy, and MSS/diploid.
Patients and methods
A total of 195 sporadic colorectal tumors and another 195 age- and gender-matched healthy volunteers in Taipei-Veteran General Hospital and Taipei City Hospital were collected. We analyzed for MTHFR (methylenetetrahydrofolate reductase) polymorphisms (C677T, A1297C), folate, and vitamin B12 levels. We determined MSI status and DNA ploidy with fluorescent polymerase chain reaction and flow cytometry. Relations between clinicopathological variables and molecular variables were analyzed by χ 2 tests (with Yates’ correction) for categorical variables and Student’s t test for numerical variables.
Folate levels (5.02±4.43 ng/ml) were significantly lower in cancer patients than in controls (7.22±4.46 ng/ml). Vitamin B12 level was similar between cancer patients and controls. The frequency of the TT genotype of MTHFR C627T (12.3%) was slightly higher than controls (8.2%), but it did not reach statistical significance (p=0.174). Within the low-folate group (<5 ng/ml), the frequency of the TT genotype in cancer patients (14.4%) was significantly higher than in controls (4.6%). Sixteen patients who had MSI-H CRC (8.2%) had a significantly higher frequency of TT MTHFR (37.5%) and lower folate levels (3.56±2.41 ng/ml) than patients with MSS tumors (10.1%, 5.14±3.72 ng/ml). Patients with MSS/aneuploid tumors had significantly lower folate levels (4.50±3.06 ng/ml) than those with MSS/diploid tumors (6.69±4.73 ng/ml).
Folate deficiency and the MTHFR genetic polymorphism play an important role in colorectal carcinogenesis, including MSI and CI.
Folate metabolism plays an important role in colorectal carcinogenesis. We demonstrate that patients with MSI-H tumors had higher frequency of TT MTHFR C627T (37.5%), and patients with MSS/aneuploid tumor had lower folate level (4.50±3.06 ng/ml).
KeywordsMTHFR Folate Microsatellite instability Chromosomal instability Colorectal cancer
hereditary nonpolyposis colorectal cancer
high microsatellite instability
This study was supported in part by grants from the Taipei Veterans General Hospital (VGH94-0172 and VGH94-0245).
- 9.Cravo M, Mason J, Dayal Y, Hutchinson M, Smith D, Selhub J et al (1992) Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats. Cancer Res 5002–5006Google Scholar
- 14.James SJ, Pogribna M, Pogribny IP, Melnyk S, Hine RJ, Gibson JB, Yi P, Tafoya DL, Swenson DH, Wilson VL, Gaylor DW (1999) Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 70:495–501PubMedGoogle Scholar
- 16.Fenech M, Baghurst P, Luderer W, Turner J, Record S, Ceppi M, Bonassi S (2005) Low intake of calcium, folate, nicotinic acid, vitamin E, retinol, beta-carotene and high intake of pantothenic acid, biotin and riboflavin are significantly associated with increased genome instability—results from a dietary intake and micronucleus index survey in South Australia. Carcinogenesis 26:991–999PubMedCrossRefGoogle Scholar
- 20.Sobin LH, Wittekind C (1997) UICC TNM classification of malignant tumors, 5th edn. Wiley-Liss, New York, pp 66–69Google Scholar
- 21.Slattery M, Potter J, Samowitz W et al (1999) Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomark Prev 8:513–518Google Scholar
- 26.Ma J, Stampfer MJ, Christensen B et al (1999) A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocysteine, and colorectal cancer risk. Cancer Epidemiol Biomark Prev 8:825–829Google Scholar
- 33.Blount BC, Ames BN (1995) DNA damage in folate deficiency. Bailliere’s Best Pract Res Clin Haematol 8:461–478Google Scholar